Seeking Alpha
Seeking Alpha Portfolio App for iPad
Finance
(1)
Market Currents

NPS Pharmaceuticals (NPSP -3.7%) gives back all its premarket gains and more, despite the...

  • Monday, November 7, 2011, 1:44 PM ET
    NPS Pharmaceuticals (NPSP -3.7%) gives back all its premarket gains and more, despite the postive Phase 3 results for its hypoparathyroid treatment earlier today. The company has been on a steady downtrend for most of this year, losing nearly 50% since hitting a 52-week high in May.
Track new comments on this story

This news story has 1 comment:

  •  
    NPSP seems like a very good buy at this point. It doesn't seem to have anywhere to go but up. The market can of course be tricky but I see a 90% chance of making a profit here.
    8 Nov 2011, 07:47 AM Reply Like
LATEST|
TODAY SO FAR|
YESTERDAY
Other date
DJIA (DIA) S&P 500 (SPY)

HEALTHCARE ETFs IN FOCUS

Latest Healthcare Articles
More Latest Articles »